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Glucagon-like peptides (GLP-1/GLP-2) are copro-
duced and highlighted as key modulators to improve
glucose homeostasis and insulin sensitivity after
bariatric surgery. However, it is unknown if CNS
GLP-2 plays any physiological role in the control of
glucose homeostasis and insulin sensitivity. We
show that mice lacking GLP-2 receptor (GLP-2R) in
POMC neurons display glucose intolerance and
hepatic insulin resistance. GLP-2R activation in
POMC neurons is required for GLP-2 to enhance
insulin-mediated suppression of hepatic glucose
production (HGP) and gluconeogenesis. GLP-2
directly modulates excitability of POMC neurons in
GLP-2R- and PI3K-dependent manners. GLP-2 initi-
ates GLP-2R-p85a interaction and facilitates PI3K-
Akt-dependent FoxO1 nuclear exclusion in POMC
neurons. Central GLP-2 suppresses basal HGP and
enhances insulin sensitivity, which are abolished in
POMC-p110a KO mice. Thus, CNS GLP-2 plays a
key physiological role in the control of HGP through
activating PI3K-dependent modulation of membrane
excitability and nuclear transcription of POMC neu-
rons in the brain.
INTRODUCTION
Insulin resistance is an important factor in the development of the
metabolic syndrome and type 2 diabetes, in which hepatic
glucose production (HGP) is not suppressed sufficiently by
insulin. Through the gut-brain axis, gut hormones play a key
role in the regulation of energy balance and glucose homeostasis
(Murphy and Bloom, 2006). In response to food intake,
glucagon-like peptide-2 (GLP-2) is coproduced with GLP-1
from endocrine L cells in the gut and preproglucagonergic86 Cell Metabolism 18, 86–98, July 2, 2013 ª2013 Elsevier Inc.(PPG) neurons in the brain. GLP-1 and GLP-2 are key signals
for the brain and pancreas to control energy balance and glucose
homeostasis and highlighted as key modulators to improve
glucose homeostasis and insulin sensitivity after gastric bypass
surgery (Field et al., 2010). GLP-1/GLP-2 receptor agonists and
DPP-IV antagonists are used clinically for the prevention and
treatment of diabetes, inflammatory bowel disease, and short
bowel syndrome (Dong and Brubaker, 2012). Thus, elucidation
of GLP-1/GLP-2 signaling and action in the control of glucose
homeostasis may reveal novel targets for the treatment of
malnutrition, obesity, and diabetes.
Through a specific Gs protein-coupled receptor (GLP-2R),
GLP-2 is essential for maintaining intestinal homeostasis and
barrier function, slowing gastric emptying and gut motility,
improving mucosal blood flow and nutrient absorption, and
enhancing immune defense (Bahrami et al., 2010b; Guan et al.,
2003). Being a key organ for digestion, absorption, and assimila-
tion, the gastrointestinal (GI) tract plays a crucial role in control-
ling energy intake. Except for its enterotrophic role, however,
GLP-2-mediated metabolic action (e.g., glucose homeostasis)
has not been adequately explored. In the GI tract, GLP-2 regu-
lates glucose homeostasis by promoting intestinal glucose
absorption (Guan et al., 2003) and pancreatic glucagon secretion
(Meier et al., 2006). In contrast, GLP-2R global deficiency in-
creases glucagon secretion and accentuates hyperglycemia
and impaired glucose tolerance in leptin-deficient (Lepob/ob)
mice (Bahrami et al., 2010a). The GLP-2R is expressed not
only in endocrine cells (such as enteroendocrine cells and
pancreatic a cells), but also in neurons (such as enteric neurons,
vagal sensory neurons, and central neurons) (Guan et al., 2006;
Nelson et al., 2007). Specifically, Glp2r mRNA is expressed in
key regions of the brain, including the hypothalamus, hippo-
campus, and the brainstem (Guan et al., 2012; Tang-Christensen
et al., 2000; Wang and Guan, 2010). As a neurotransmitter,
GLP-2 may mediate PPG neuron-induced synaptic transmission
linking the hypothalamus and the brainstem (Tang-Christensen
et al., 2000) and acts as a key physiological satiation signal (for
short-term energy availability) in the control of feeding behavior
and gastric emptying, which may contribute to the homeostatic,
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et al., 2012). However, it is unknown if CNS GLP-2 plays any
physiological role in the control of glucose homeostasis and
insulin sensitivity.
The hypothalamus plays pivotal roles not only in the regulation
of energy balance but also in the maintenance of glucose
homeostasis (Schwartz and Porte, 2005). Pro-opiomelanocortin
(POMC) is expressed in the arcuate nucleus of the hypothalamus
(ARC) and the nucleus of the tractus solitarius (NTS) of the brain-
stem. POMC neurons are perfectly positioned to integrate
long-term adiposity and short-term satiety signals for energy
homeostasis (Cone, 2005). Direct action of leptin and insulin on
POMC neurons regulates HGP in mice and rats (Berglund
et al., 2012; Hill et al., 2010; Lin et al., 2010). GLP-2R is localized
to the mouse ARC POMC neurons, and i.c.v. administration of
GLP-2 increases ARC Pomc mRNA abundance (Guan et al.,
2012). Therefore, we hypothesized that GLP-2R in POMC neu-
rons plays an important physiological role in the control of
glucose homeostasis and insulin sensitivity.
The PI3K-Akt-FoxO1 axis is a key signaling pathwaymediating
hormonal and nutritional actions in the brain. PI3K-dependent
Akt activation inhibits FoxO1 activity. GLP-2 activates PI3K-Akt
signaling in hippocampal neurons (Shi et al., 2011). As a major
catalytic subunit of PI3K, p110a is required for leptin- and
insulin-induced PI3K activity in the hypothalamus (Koch et al.,
2010). Thus, we hypothesized that PI3K signaling in POMC
neurons is required for CNS GLP-2 to promote glucose homeo-
stasis and enhance insulin sensitivity.
In the present study, we show that Glp2r deletion in POMC
neurons impairs postprandial glucose tolerance and hepatic
insulin sensitivity. GLP-2 directly modulates postsynaptic excit-
ability of POMC neurons in GLP-2R- and PI3K-dependent
manners. By inducing GLP-2R-p85a interaction, GLP-2 acti-
vates PI3K-Akt-FoxO1 signaling in POMC neurons. Glp2r and
p110a in POMC neurons are required for i.c.v. GLP-2 to sup-
press HGP. Therefore, the CNS GLP-2R plays a key role in the
control of glucose homeostasis and insulin sensitivity via
GLP2R-PI3K-mediated central melanocortin system, which is
independent of conventional incretin-mediated insulin action.
RESULTS
GLP-2R Deletion in POMC Neurons Impairs Hepatic
Insulin Sensitivity
GLP-2R in POMC neurons is required for the control of feeding
behavior and gastric emptying. However, it is unknown if GLP-
2R in POMC neurons modulates glucose homeostasis and
insulin sensitivity. To determine the functional role of GLP-2R
in POMC neurons, we genetically engineered mice that lack
GLP-2R specifically in POMC neurons by crossing Glp2rflox/flox
mice with POMC-Cre mice. Glp2r deletion in POMC neurons
was validated by immunohistochemistry (Guan et al., 2012).
Moreover, Glp2r mRNA expression was markedly attenuated
in the neurons within the ARC of POMC-Glp2r KO (POMC-
Cre+/0, Glp2rflox/flox) mice as compared to WT (POMC-Cre0/0,
Glp2rflox/flox) mice (Figure S1). There were no differences in
Glp2r mRNA expression in non-ARC regions such as the para-
ventricular nucleus of the hypothalamus (PVH) and hippocampus
(Figure S1). Glp2r protein expression was not altered in the PVHeither (Figure S1). Of note, 94.5%± 4.9%of POMC-GFP neurons
were GLP-2R immunoreactive, while 48.2% ± 8.5% of GLP-2R-
immunoreactive cells were POMC-GFP neurons, indicating
GLP-2R expression in non-POMC neurons within the ARC.
POMC-Glp2r KO mice (at 10 weeks old) displayed glucose in-
tolerances during postprandial status and ipGTT, though fasting
and as-fed glucose levels were not altered (Figures 1A–1C).
Moreover, serum insulin levels in the KO mice were increased
at fast and 2 hr postprandial statuses (Figure 1D), probably
suggesting insulin resistance per se. To dissect tissue-specific
insulin effects, we determined the mouse whole-body insulin
sensitivity using hyperinsulinemic euglycemic clamp coupled
with stable isotopic tracers (2H2O and 6,6-
2H2-glucose). The pro-
tocol for quantifying glucose kinetics is shown in Figure S2. Note
that (1) insulin was infused at a relative low rate, (2) the ratio of
labeled glucose versus unlabeled glucose was kept constant in
the infusate and thus was diluted exclusively by endogenous
glucose, and (3) the physiological equilibration of labeled
glucose was achieved within 3 hr, conditions that allow us to
examine glucose homeostasis under relatively physiological
conditions. It took 2–3 hr for 12 hr-fasted 10-week-old mice
to reach a plateau of isotopic enrichment (i.e., 2H-glucose). In
fact, glucose infusion rate (GIR) reached a plateau within
2–3 hr when blood glucose was clamped at 110 mg/dl. Of
note, estimates for glucose kinetics were influenced by
insulin infusion rate. When insulin was infused from 2.5 to
5.0 mU/kg/min, GIR was increased by 20% (from 7.65 ± 0.30
to 9.21 ± 0.35mmol/kg/hr), and endogenous glucose production
(i.e., HGP) decreased by 85% (from 1.93 ± 0.14 to 0.33 ±
0.25 mmol/kg/hr), though glucose disappearance rate (Rd, i.e.,
glucose uptake by peripheral tissues) was not altered (from
9.75 ± 0.28 to 9.35 ± 0.42mmol/kg/hr). When insulin was infused
at a higher rate of 5.0 mU/kg/min, HGP was completely sup-
pressed and undistinguished between genotypes. Therefore,
insulin was primed at 150 mU/kg and infused continuously at
2.5 mU/kg/min while glucose was infused at varied rates to
maintain a euglycemic level (110 ± 5 mg/dl) throughout this
study.
GLP-2R deletion in POMC neurons impairs whole-body
glucose metabolism (Figures 1F–1I). For the insulin clamp, there
were no differences in body weight or fat mass between two
groups (Table S3). In the WT mice, infusion of insulin
(2.5 mU/kg/min) increased Rd by 2.5-fold, decreased HGP by
20%, and decreased gluconeogenesis by 43% when compared
to their basal values. Importantly, GIR (an indicator of whole-
body insulin sensitivity) decreased by 26.6% in POMC-Glp2r
KO mice compared to their WT littermates. During the clamp,
Rd (an indicator of insulin-stimulated uptake of glucose by
peripheral tissues) was not different between two genotypes.
However, HGP during the clamp (an indicator of insulin-sup-
pressed glucose production by liver) increased by 47.5% in
POMC-Glp2r KOmice compared to theirWT littermates. Propor-
tionally, gluconeogenesis also increased by 41.4% in the KO
mice. In agreement with glucose kinetics data, hepatic mRNA
abundances of G6Pase and PEPCK (two key gluconeogenic
genes) after the insulin clamp were higher in the POMC-Glp2r
KO than those in the WT mice (Figure S2).
In terms of blood hormonal profile, we found that, compared to
the WT littermate, the POMC-Glp2r KO mice displayed higherCell Metabolism 18, 86–98, July 2, 2013 ª2013 Elsevier Inc. 87
Figure 1. GLP-2R Deletion in POMC Neurons Impairs Glucose Homeostasis and Insulin Sensitivity
(A) Blood glucose levels at 8–24 hr fast or as-fed.
(B) Blood glucose levels during refeeding.
(C) POMC-Glp2r KO mice display glucose intolerance.
(D) Serum insulin levels at 12 hr fast and 2 hr postprandial statuses.
(E) GLP-2R deletion in POMC neurons impairs insulin-suppressed glucagon secretion.
(F) POMC-Glp2r KO mice display whole-body insulin resistance indicated by lower GIRs during the clamp.
(G) Glucose disappearance rate (Rd) was not altered in POMC-Glp2r KO mice.
(H and I) POMC-Glp2r KO mice display hepatic insulin sensitivity indicated by higher endogenous glucose production (i.e., HGP) and gluconeogenesis. Ten-
week-old mice (with similar BW and fat mass) were assessed for glucose tolerance by intraperitoneal (i.p.) glucose tolerance test and quantified for glucose
homeostasis and insulin sensitivity using stable isotopic tracers during hyperinsulinemic euglycemic clamp. Data are expressed as means ± SEM (n =8–12 per
group); y, *, and **p < 0.10, 0.05, and 0.01, respectively, denoting significance between genotypes at the same time point or between baseline and clamp within a
genotype; a,b and a,cp < 0.05 and 0.01, respectively, denoting significance between genotypes during the clamp (C–H). See also Figures S1 and S2 and Table S3.
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(Figure 1D). However, there was no difference in basal serum
GLP-1 (7–36) amide concentrations (the KO versus WT mice:
1.83 ± 0.01 versus 1.85 ± 0.05 pM). Glucagon is a major driving
force behind increased HGP while glucagon secretion is regu-
lated by vagal input. Since GLP-2R global KO mice display
enhanced secretion of glucagon, we wanted to determine if
increased HGP in POMC-Glp2r KO mice is associated with
increased glucagon secretion. Notably, blood glucagon concen-
trations during the clamp were suppressed in the WT mice, but
not altered in the KOmice (Figure 1E), although their basal levels88 Cell Metabolism 18, 86–98, July 2, 2013 ª2013 Elsevier Inc.were similar. These data indicate that Glp2r deletion in POMC
neurons leads to hepatic insulin resistance associated with
impairment in insulin-suppressed secretion of glucagon, sug-
gesting that GLP-2R in POMC neurons is required for insulin-
mediated suppression of HGP (i.e., gluconeogenesis).
GLP-2R Activation in POMC Neurons Is Required for
GLP-2 to Promote Glucose Homeostasis and Enhance
Insulin Sensitivity
POMC neurons in the ARC can sense peripheral hormones and
nutrients. We speculate if peripheral GLP-2 may directly act on
Figure 2. Peripheral and Central GLP-2 Augments Hepatic Insulin Sensitivity through GLP-2R Function in POMC Neurons
(A–F) i.v. GLP-2 administration and (G–L) i.c.v. GLP-2 administration. (A) and (G) show protocols for quantifying glucose homeostasis and insulin sensitivity under
peripheral and central infusion of GLP-2. (B) and (H) show HGP or gluconeogenesis at the baseline. (C)–(F) and (I)–(L) show that peripheral and central GLP-2
improve insulin sensitivity in theWTmice during the insulin clamp, respectively, as indicated by higher GIR, lower HGP, and gluconeogenesis. These effects were
negated in POMC-Glp2r KOmice. Notably, central GLP-2, not peripheral GLP-2, enhanced glucose disappearance rate in the KOmice. Ten-week-old mice (with
similar BW and fatmass) were infused peripherally with GLP-2 (500 pmol/kg/hr) via a jugular vein catheter for 3 hr or centrally withGLP-2 (250 mMat a rate of 0.5 ml/
hr) via a micro-osmotic pump for 3 days and meanwhile quantified for insulin sensitivity using stable isotopic tracers during hyperinsulinemic euglycemic clamp.
Data are expressed as means ± SEM (n =8–12 per group); ** or *p < 0.01 or 0.05, denoting significance between genotypes during the clamp; a,b and a,cp < 0.05
and 0.01, respectively, denoting significance between genotypes during the clamp. See also Figure S2 and Table S3.
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permeable. Alternatively, peripheral GLP-2 may act GLP-2R on
the vagal (afferent) neurons and consequently activate neurons
in the brainstem and hypothalamus, i.e., GLP-2 may indirectly
act on ARC POMC neurons. Thus, we hypothesized that GLP-
2R on POMC neurons was required for acute i.v. GLP-2 to pro-
mote glucose homeostasis. To address it, we examined glucose
homeostasis under acute 3 hr i.v. infusion of GLP-2 (at 500 pmol/
kg/hr) or vehicle during insulin clamp (Figures 2A–2F). Consis-
tently, there were no differences in basal HGP or gluconeogen-
esis between the WT and KO mice prior to i.v. GLP-2 (or vehicle)
infusion. Acute i.v. infusion (3–4 h) of GLP-2 enhanced the
whole-body insulin sensitivity (indicated by increased GIR) in
the WT mice through further increasing peripheral glucose
disposal (indicated by increased Rd) and suppressing HGP
and gluconeogenesis. However, i.v. GLP-2-induced enhance-
ment in insulin sensitivity was negated in POMC-Glp2r KO
mice, indicating that Glp2r in POMC neurons is required for i.v.
GLP-2 acute action in the control of insulin sensitivity and
glucose homeostasis.As we reported recently, i.c.v. GLP-2 suppresses food intake
and gastric emptying, and this is mediated by Glp2r in POMC
neurons (Guan et al., 2012). It is unknown if and how i.c.v.
GLP-2 promotes glucose homeostasis and insulin sensitivity.
We hypothesized that GLP-2R in POMC neurons was a key site
for central GLP-2 action on peripheral glucose homeostasis. To
test it, we performed the insulin clamp in mice after a 3 day
i.c.v. infusion of GLP-2 (Figures 2G–2L). Three day i.c.v. infusion
of GLP-2 enhanced the whole-body insulin sensitivity (indicated
by increased GIR) in the WT mice through further increasing
peripheral glucose disposal (indicated by increasedRd) and sup-
pressing HGP and gluconeogenesis. However, i.c.v. GLP-2-
induced suppression of HGP and gluconeogenesis was negated
in POMC-Glp2r KOmice, indicating that Glp2r in POMC neurons
is required for i.c.v. GLP-2 to suppressHGP.Of note, i.c.v. GLP-2
suppressed basal HGP. Interestingly, i.c.v. GLP-2 still enhanced
peripheral glucose disposal (indicated by increasedRd) in theKO
mice. This is consistent with a current view that ARC POMC neu-
rons control glucose production while VHM (or DMH) neurons
modulate glucose disposal. Both i.v. GLP-2 and i.c.v. GLP-2Cell Metabolism 18, 86–98, July 2, 2013 ª2013 Elsevier Inc. 89
Figure 3. GLP-2 Directly Modulates Membrane Excitability of Hypothalamic POMC Neurons in GLP-2R- and PI3K-Dependent Manners
(A) POMC neurons in the arcuate are identified by POMC promoter-driven GFP expression.
(B) mRNA expression of hormonal receptors in recorded POMC neurons was determined by single-cell RT-PCR.
(C–G) In (C), (E), and (G), GLP-2 depolarizes POMC neurons expressing leptin receptor. GLP-2 (100 nM) depolarized 22 of 44 POMC neurons as indicated by
increased spontaneous firing rate and decreased resting membrane potential. Under the presence of tetrodotoxin (TTX, 1 mM), GLP-2 still depolarized 10 of 22
POMC neurons, indicating a direct action on membrane depolarization of POMC neurons independent of action potential (AP)-mediated synaptic transmission.
This subgroupof POMCneurons expressed leptin receptor (LepR)mRNA,but not insulin receptor (InsR)mRNA (B). In (D), (F), and (G), GLP-2 hyperpolarizes POMC
neurons expressing insulin receptor. GLP-2 (100 nM) also hyperpolarized 18 of 44 POMC neurons as indicated by decreased firing rate and increased resting
membrane potential. Under the presence of TTX (1 mM), GLP-2 still hyperpolarized 10 of 22 POMC neurons, indicating a direct action on membrane hyperpo-
larization of POMCneurons independent of AP-mediated synaptic transmission. This subgroup of POMCneurons expressed InsRmRNA, but not LepRmRNA (B).
(H–J) GLP-2R in POMC neurons is required for GLP-2-inducedmodulation of membrane excitability. GLP-2 (100 nM) neither depolarized nor hyperpolarized 11 of
12 of POMC neurons with GLP-2R deletion. Neither spontaneous firing rate nor resting membrane potential were observed in response to GLP-2 in POMC
neurons with Glp2r deletion, indicating GLP-2-mediated action on membrane potential through GLP-2R function in POMC neurons.
(K–M) GLP-2 action on POMC neuronal excitability is blocked by PI3K inhibitor. GLP-2 (100 nM) did not excite or inhibit POMC neurons (n = 12) after the brain
slides were treated with LY-294002 (10 mM), indicating GLP-2 action in a PI3K-dependent manner. (C), (D), and (K) show representative traces of the whole-cell
patch clamp recordings on POMC neurons in WT (i.e., Glp2rflox/flox; POMC-GFP+/0) brain slices, while (H) shows representative traces of the whole-cell patch
clamp recordings on POMCneurons in KO (i.e.,Glp2rflox/flox; POMC-Cre+/0; POMC-GFP+/0) brain slices. Membrane potential and firing rate weremeasured by the
whole-cell current clamp recording and analyzed withMini Analysis Program. After thewhole-cell patch clamp recording, single neuronswere ad hoc acquired for
RT-PCR. Data are expressed as means ± SEM; **p < 0.01 denotes significance between control and GLP-2 (±TTX); and NS denotes no significance (p > 0.1)
between GLP-2 and GLP-2 plus TTX (G). See also Figure S3.
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However, i.c.v. GLP-2 might also act on GLP-2R in the DMH
and stimulate glucose disposal (Rd) where i.v. GLP-2 could not
reach. Regardless of GLP-2 origin, GLP-2R activation is required
for GLP-2 to promote glucose homeostasis.
GLP-2 Differentially Modulates the Excitability of POMC
Neurons in a PI3K-Dependent Manner
POMC neurons in the hypothalamus play a key role in the regu-
lation of HGP. The metabolic phenotype of POMC-Glp2r KO
mice suggests that GLP-2R in POMC neurons is involved in
the control of glucose homeostasis. Moreover, i.c.v. infusion of90 Cell Metabolism 18, 86–98, July 2, 2013 ª2013 Elsevier Inc.GLP-2 (at 250 pmol/ml at 0.5 ml/hr for 3 days) improved glucose
homeostasis (Figures 2G–2L) with increased ARC Pomc mRNA
abundance. Though GLP-2R is expressed in POMC neurons, it
is unknown if GLP-2 can directly modulate their excitability. To
determine GLP-2 induced action on POMC neuronal excitability,
we performed whole-cell patch-clamp recording on brain slices
from POMC-Glp2r WT (POMC-eGFP+/0, Glp2rflox/flox) and
POMC-Glp2r KO (POMC-Cre+/0, POMC-eGFP+/0, Glp2rflox/flox)
mice. POMC neurons were identified by POMC promoter-driven
eGFP expression (Figure 3A).
We found that GLP-2 (perfused at 100 nM) depolarized 50%
(22 of 44) POMCneurons as indicated by increased spontaneous
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3C, 3E, and 3G). Hormonal regulation of POMC neuron activity
involves both cell-autonomous and presynaptic effects. Of
note, GLP-2 effects occurred with an onset <5 min in our prepa-
ration (Figure S3), similar to leptin effects on membrane potential
of POMC neurons (Hill et al., 2008). The GLP-2-induced depolar-
ization was partially reversible within18 min, probably pointing
to GLP-2R-mediated homologous desensitization. To define if
this excitation is mediated by action potential (AP)-dependent
synaptic transmission, tetrodotoxin (TTX, a fast sodium channel
blocker, 1 mM) was coperfused with GLP-2. Clearly, GLP-2 still
depolarized 45% (10 of 22) POMC neurons (as membrane
potential decreased by 3.97 ± 0.8 mV; n = 10; Figure 3G), indi-
cating a direct action on membrane depolarization in POMC
neurons independent of AP-mediated synaptic transmission.
Representative traces of TTX preblockage procedure were
shown in Figure S3. Moreover, single-cell RNA was obtained
ad hoc after the recording. Interestingly, the single-cell RT-
PCR showed that leptin receptor (LepR) mRNA was expressed,
but insulin receptor (InsR) mRNA was not, in this subgroup of
POMC neurons (Figure 3B).
In contrast, GLP-2 (100 nM) also hyperpolarized 40% (18 of
44) POMC neurons as indicated by decreased spontaneous
firing rate and increased resting membrane potential (Figures
3D, 3F, and 3G). In the presence of TTX (1 mM), GLP-2 still hyper-
polarized45% (10 of 22) POMC neurons (as membrane poten-
tial increased by 9.6 ± 1.7 mV; n = 10; Figure 3G), indicating a
direct action on membrane hyperpolarization in POMC neurons
independent of AP-mediated synaptic transmission. Moreover,
the single-cell RT-PCR showed that InsR was expressed, but
LepR mRNA was not, in this subgroup of POMC neurons
(Figure 3B).
Importantly, GLP-2 (100 nM) neither depolarized nor hyperpo-
larized 90% (11 of 12) of POMC neurons in the brain slices
from the POMC-Glp2r KO mice (Figure 3H). GLP-2-induced
excitation (or inhibition) was abolished in POMC neurons with
Glp2r deletion since no changes were observed in spontaneous
firing rate or resting membrane potential in slices from these
mice (Figures 3I and 3J), further indicating GLP-2-mediated
direct action on membrane potential (not attributable to synaptic
transmission) through GLP-2R function in POMC neurons. Inter-
estingly, the resting membrane potential was at 45 mV, i.e.,
approximately 5 mV lower in POMC neurons from the POMC-
Glp2r KO mice than those from the WT mice. These data not
only indicate that GLP-2 differentially modulates membrane
excitability of POMC neurons, but also suggest that Glp2r is
required for maintaining the basal membrane potential of
POMC neurons.
GLP-2modulates firing rate andmembrane potential of POMC
neurons in a PI3K-dependent manner. PI3K signaling is required
for leptin and insulin to activate TRPC and KATP channels,
respectively, resulting in depolarization and hyperpolarization
of POMC neurons (to suppress and promote glucose produc-
tion). GLP-2 rapidly phosphorylates Akt in primary neurons in a
PI3K-dependent manner (Shi et al., 2011), suggesting that the
PI3K-Akt signaling pathwaymay underlie GLP-2-inducedmodu-
lation of POMC neurons. Therefore, we examined whether PI3K
activation is required for GLP-2 action on neuronal excitability
and found that pretreatment of brain slides with LY-294002(a PI3K inhibitor, 10 mM) completely blocked the effects of
GLP-2 (100 nM) on POMCneurons (n = 12) (Figures 3K–3M), indi-
cating that GLP-2 modulates firing rate and membrane potential
of POMC neurons in a PI3K-dependent manner.
To further define which ion channels were attributed to GLP-2-
modulated neuronal excitability, we assessed how POMC neu-
rons responded to GLP-2 in the presence of tolbutamide (an
ATP-dependent K+ channel blocker). While 37.5% of POMC
neurons were excited (as indicated by increased firing rate and
decreased membrane potential; Figure S3), 62.5% of POMC
neurons were unresponsive to GLP-2 (100 nM) in the presence
of tolbutamide (200 mM), indicating either K+ATP blockage or
unresponsiveness per se. Thus, K+ATP activation was respon-
sible for GLP-2-induced inhibition of POMC neurons.
In summary, we show that GLP-2 directly modulates excit-
ability of POMC neurons in GLP-2R- and PI3K-dependent
manners. GLP-2 depolarizes one subgroup of POMC neurons
expressing LepR, but hyperpolarizes another subgroup of
POMC neurons expressing InsR, indicating that GLP-2 is a key
modulator in the central melanocortin system that may mediate
CNS GLP-2-induced suppression of HGP. However, little is
known about CNS GLP-2-mediated intracellular signaling
pathways in these neurons.
GLP-2R Binds to PI3K and Activates PI3K-Akt-FoxO1
Signaling in POMC Neurons
PI3K is recruited to the phosphotyrosine residues (consensus
sequence YXXM) via SH2 domains in the regulatory domain
(p85), leading to changes in the catalytic domain (p110) confor-
mation and then PI3K activation. Through GLP-2R primary
sequence analysis, we found a putative p85a-binding motif
(YXXM) in the GLP-2R amino acid sequence (Figure S4).
To determine if GLP-2R directly interacts with the PI3K regula-
tory subunit (p85a), we performed immunoprecipitation (IP) in
primary neurons (DIV 7) treated with GLP-2 at 20 nM for
15–30 min. Since it is technically challenging to culture mature
neurons from the hypothalamus, neurons from the hippocampus
were cultured for investigating GLP-2R function as we reported
previously (Wang andGuan, 2010).We found that in the coimmu-
noprecipitated (coIP) protein complex with rabbit GLP-2R
antibody, a protein band of the p85a at the predicted size was
detected by immunoblotting (IB) using mouse p85a antibody
(in Figure 4A). Conversely, in coIP protein complex with mouse
p85a antibody, a protein band of the GLP-2R at the predicted
size was detected by IB using rabbit GLP-2R antibody. Of
note, this interaction (between GLP-2R and p85a) was activated
by GLP-2 addition and refeeding (Figure S4B). Moreover, this
GLP-2R-p85a interaction was confirmed in HEK293 cells trans-
fectedwith Glp2r-c-myc and p85a-GFP using antibodies against
c-myc and GFP (Figure 4B). Note that c-myc multiple bands are
related to GLP-2R glycosylation in HEK293 cells. Moreover, the
p85a binding motif (YXXM) on human Glp2r was mutated to the
AXXA sequence to determine if the motif was responsible for
GLP-2R-PI3K activation. In wild-type Glp2r-transfected cells,
GLP-2 (at 20 nM for 30 min) enhanced Akt phosphorylation at
both Ser473 and Thr308 (Figure S4). In the mutant Glp2r-trans-
fected cells, in contrast, GLP-2 enhanced Akt phosphorylation
only at Ser473, but not at Thr308, suggesting that the p85a
binding motif (of GLP-2R) was essential for GLP-2-inducedCell Metabolism 18, 86–98, July 2, 2013 ª2013 Elsevier Inc. 91
Figure 4. GLP-2 Activates PI3K-Dependent Akt Signaling by Inducing GLP-2R-p85a Interaction
(A) GLP-2R interacts with p85a in cultured hippocampal neurons. Upper panel: In GLP-2R-coIP protein complex, a protein band (p85a) was detected by
immunoblotting (IB). Bottom panel: Conversely, in p85a-coIP protein complex, a protein band (GLP-2R) was detected by IB.
(B) GLP-2R interacts with p85a in transfected HEK293 cells. The GLP-2R-p85a interaction was confirmed in HEK293 cells transfected with Glp2r-c-myc plus
p85a-GFP, but not in the control. Upper panel: In c-myc (i.e., GLP-2R)-coIP protein complex, a protein band (GFP, i.e., p85a) was detected by IB. Bottom panel:
Conversely, in GFP (i.e., p85a)-coIP protein complex, a protein band (c-myc, i.e., GLP-2R) was detected by IB.
(C) GLP-2 induces p-AKTmembrane localization in cultured neurons. p-Akt Ser473 was translocated to the plasmamembrane (indicated in white arrows in (C)) in
cultured neurons after treatment with GLP-2 (at 20 nM for 30 min).
(D) GLP-2 increases PI3K-dependent phosphorylated Akt abundance in cultured neurons. p-Akt Ser473 abundance increased in cultured neurons after treatment
with GLP-2 (at 20 nM for 30 min), but not in the pretreatment of PI3K inhibitor (LY294002, 50 mM). Hippocampal neurons and transfected HEK293 cells were
cultured, and treated with vehicle, GLP-2, or GLP-2 plus LY294002 for immunocytochemistry or immunoblotting after coIP. See also Figure S4.
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the Akt full activation.
To define if GLP-2 activates PI3K-Akt signaling in cultured
neurons, we determined the protein abundance and cellular
localization of phosphorylated Akt (Akt as a PI3K substrate). It
is known that PI3K phosphorylates PIP2 to generate PIP3 at
the plasma membrane where Akt is bound to PIP3 and activated
by PDK1. GLP-2 (20 nM for 30 min) increased the p-Akt Ser473
protein abundance in cultured neurons, and this effect was
abolished after pretreatment with LY-294002 (50 mM, Figure 4D).
Importantly, the p-Akt was translocated to the plasma mem-
brane (in white arrows in the bottom middle panel of Figure 4C)
in cultured neurons after treatment with GLP-2 (20 nM) for
30 min, while p-Akt was mainly localized to the nucleus (in white
stars in the top middle panel of Figure 4C). In summary, we show
in cultured primary neurons and transfected cells that GLP-2
activates the PI3K-dependent Akt signaling through GLP-2R-
p85a interaction.
FoxO1 is a downstream target of the PI3K/Akt signaling
pathway and regulates energy balance (Kim et al., 2006). Impor-
tantly, Akt1 phosphorylates FoxO1, leading to its retention in the
cytoplasm (i.e., nuclear exclusion) and disinhibition of target92 Cell Metabolism 18, 86–98, July 2, 2013 ª2013 Elsevier Inc.gene expression (such as Pomc and Cpe) in POMC neurons
(Plum et al., 2009; Kim et al., 2006). Thus, FoxO1-GFP nuclear
exclusion not only indicates transcriptional function of FoxO1
per se, but also represents activation of PI3K-Akt signaling
pathway in a neuron-specific manner (Fukuda et al., 2008).
Therefore, we tested if GLP-2-induced activation of PI3K-Akt
signaling pathway was associated with FoxO1-GFP nucleocyto-
plasmic shuttling in POMC neurons. To quantify if GLP-2 acutely
induces PI3K-dependent nuclear exclusion of FoxO1-GFP in
POMC neurons, brain slices were cultured and treated with
GLP-2 (20 nM for 30 min). Of note, FoxO1-GFP was expressed
in a Cre-dependent manner. To determine if Glp2r in POMC
neurons is required for GLP-2 to enhance Akt-FoxO1 signaling,
we analyzed the cellular distribution of p-Akt and FoxO1-GFP
in brain slices by immunocytochemistry. As shown in Figure S5,
FoxO1-GFP was localized exclusively to the nucleus with
attenuated p-Akt in ARC POMC neurons of POMC-Glp2r KO
(POMC-Cre+/0; Glp2rflox/flox; FoxO1-GFP+/0) brain slices, while
FoxO1-GFP was localized to both the nucleus and cytoplasm
with basal p-Akt in POMC neurons of the WT (POMC-Cre+/0;
FoxO1-GFP+/0) brain slides. Moreover, GLP-2 promoted Akt
phosphorylation and FoxO1-GFP nuclear exclusion in the brain
Figure 5. GLP-2 Activates the PI3K-Akt-
FoxO1 Signaling in POMC Neurons
(A) FoxO1-GFP nuclear exclusion as readout of
PI3K activation.
(B) GLP-2 induces FoxO1-GFP nuclear exclusion
in POMC neurons in a p110a-dependent manner.
(C) GLP-2 induces FoxO1-GFP nuclear exclusion
in POMC neurons.
In GLP-2-treated WT brain slice (i.e., from POMC-
Cre+/0; FoxO1-GFP+/0 mice), FoxO1-GFP is mainly
localized to the cytoplasm of POMC neurons
where p-AKT staining was enhanced (in arrows).
(D) In GLP-2-treated KO brain slides (i.e., from
POMC-Cre+/0; p110aflox/flox; FoxO1-GFP+/0 mice),
FoxO1-GFP is still dominantly localized to the
nucleus of POMC neurons although p-Akt
signaling is enhanced in adjacent cells (in stars).
Brain slices (250 mm) were cultured and treated
with vehicle or GLP-2 (at 20 nM for 30min). FoxO1-
GFP and p-Akt Ser473 were immunostained and
quantified. Data are expressed as means ± SEM;
**p < 0.01 denoting significance between vehicle
and GLP-2 within a genotype. See also Figure S5.
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maintained in the nucleus of POMC neurons, though p-Akt
signaling was enhanced in adjacent neurons, in the brain slices
of POMC-Glp2r KO mice. These data suggest that Glp2r in
POMC neurons is required for GLP-2 to activate Akt-FoxO1
signaling.
To genetically define if GLP-2 activates the PI3K-Akt-FoxO1
signaling in POMC neurons, we monitored the nuclear exclusion
of FoxO1-GFP in POMC neurons expressing or lacking p110aCell Metabolism 18,(the PI3K catalytic subunit) in response
to GLP-2 treatment (20 nM for 30 min).
GLP-2 acutely induced nuclear exclu-
sion of FoxO1-GFP in POMC neurons
as decreased from 80% to 20% of
FoxO1-GFP exclusively localized to the
nucleus in POMC-p110a WT brain slices
(i.e., from POMC-Cre+/0; FoxO1-GFP+/0
mice), while this nuclear exclusion
was abolished in POMC neurons in
POMC-p110a KO brain slices (i.e., from
POMC-Cre+/0; p110aflox/flox; FoxO1-
GFP+/0 mice) (Figure 5B). Interestingly,
FoxO1-GFP in the cytoplasm was colo-
calized with p-AKT (as shown in yellow,
see arrows) in POMC neurons of the
WT brain slides (Figure 5C). In contrast,
p-Akt signaling was enhanced, but not
colocalized with FoxO1-GFP in POMC
neurons of the KO brain slides (indicated
in stars in Figure 5D). Those phar-
macological and genetic data indicate
that GLP-2R interacts physically with
the PI3K regulatory subunit (p85a) and
is required for the basal activation of
p-Akt in POMC neurons. Moreover,
GLP-2 enhances PI3K-dependent p-Aktsignaling, facilitating FoxO1 nuclear exclusion in hypothalamic
POMC neurons.
PI3K in POMC Neurons Is Required for i.c.v. GLP-2-
Enhanced Insulin Sensitivity and Glucose Homeostasis
As we demonstrated above, Glp2r in POMC neurons is essential
for insulin-mediated suppression of HGP. To determine whether
i.c.v. GLP-2 affects glucose homeostasis and insulin sensitivity,
we infused into i.c.v. through an osmotic pump with GLP-286–98, July 2, 2013 ª2013 Elsevier Inc. 93
Figure 6. p110a in POMC Neurons Is Required for i.c.v. GLP-2-Enhnaced Insulin Sensitivity and Glucose Homeostasis
(A) Protocol for quantifying glucose homeostasis and insulin sensitivity under 3 day i.c.v. infusion of GLP-2.
(B) Blood glucose concentrations after an overnight fast.
(C) Eight day i.c.v. infusion of GLP-2 augments glucose tolerance under ipGTT.
(D) Basal HGP is suppressed by 3 day i.c.v. infusion of GLP-2 in the WT, but not KO.
(E and F) Insulin sensitivity during the clamp is enhanced by 3 day i.c.v. infusion of GLP-2 as indicated by higher GIR and glucose disappearance rate in the WT
mice, but not in the KO mice.
(G and H) HGP/gluconeogenesis during the clamp is not further suppressed by i.c.v. GLP-2.
(I) A model for CNS GLP-2R action on POMC neurons in suppressing HGP. Transcriptionally, CNS GLP-2 activates PI3K-Akt-FoxO1 signaling in POMC neurons
as indicated by initiating GLP-2R-PI3K regulatory subunit (p85a) interaction, enhancing PI3K-dependent Akt (Ser473) phosphorylation and inducing FoxO1
nuclear exclusion in POMC neurons, disinhibiting Pomc expression. In addition, through the PI3K-dependent signaling pathway, GLP-2 excites and inhibits
LepR-positive and InsR-positive POMC neurons, respectively. GLP-2-mediated direct action on POMC neurons contributes at least in part to suppressing HGP
and gluconeogenesis, probably through vagal efferent output to the liver. Ten-week-old mice (with similar BW and fat mass) were infused i.c.v. with vehicle (aCSF)
or GLP-2 (250 mMat 0.5 ml/hr) via amicro-osmotic pump. Glucose homeostasis and insulin sensitivity were quantified using intraperitoneal (i.p.) glucose tolerance
test after 8 day i.c.v. infusion and stable isotopic tracers (2H2O and 6,6-
2H2-D-glucose) coupled with hyperinsulinemic euglycemic clamp after 3 day i.c.v. infusion.
Data are expressed as means ± SEM (n = 8 per group); **p < 0.01 denotes significance in WT mice between vehicle and GLP-2 at the same points (C), during
baseline (D), or during clamp (E and F); a,b or a,cp < 0.05 or 0.01 denotes significance between genotypes during the baseline (D) or clamp (E). See also Figures S2
and S6 and Table S3.
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basal HGP in theWTmice as shown in Figures 2G–2L. In another
experiment, C57BL/6J mice were i.c.v. infused with GLP-2 for
8 days and had increased glucose tolerance (during ipGTT) (Fig-
ure 6C). Fasting glucose levels were not altered by 8 day i.c.v.
infusion of GLP-2. Moreover, basal HGP in POMC-p110a WT
(POMC-Cre0/0, p110aflox/flox) mice was suppressed (28%) by
3 day i.c.v. infusion of GLP-2, and this CNS GLP-2 suppression
of HGP was abolished in POMC-p110a KO (POMC-Cre+/0,
p110aflox/flox) mice (Figure 6). During the insulin clamp, blood
glucose concentrations were clamped at the same level
(108.0 ± 6.5 mg/dl) in all four groups (Figure S6). Of note, there94 Cell Metabolism 18, 86–98, July 2, 2013 ª2013 Elsevier Inc.was no difference in BW between treatments or genotypes
when the insulin clamp was performed (Table S3). In the vehicle
groups, p110a deletion in POMC neurons negatively regulated
the basal HGP (5.08 ± 0.30 versus 2.92 ± 0.54 mmol/kg/hr,
respectively, for the WT and KO mice). Furthermore, i.c.v. infu-
sion of GLP-2 enhanced whole-body insulin action in the
WT mice (as increased GIR, i.e., 8.40 ± 0.36 and 7.43 ±
0.40 mmol/kg/hr, respectively, for the GLP-2 and vehicle
groups), but did not impact it in POMC-p110a KO mice. It
is important to note that GIR in the vehicle control was
lower in POMC-p110a KO mice compared to their WT
littermates. Consistently, i.c.v. infusion of GLP-2 enhanced
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tissues in the WT mice (as increased Rd, i.e., 8.93 ± 0.58 and
11.49 ± 0.46mmol/kg/hr, respectively, for the GLP-2 and vehicle
groups), but did not improve it in the KOmice. Of note, i.c.v. infu-
sion of GLP-2 did not further decrease insulin-suppressed HGP
or gluconeogenesis in both genotypes. These data clearly
demonstrate that CNS GLP-2 suppresses HGP and enhances
insulin sensitivity. PI3K in POMC neurons is required for CNS
GLP-2-mediated improvement in insulin sensitivity. In fact,
p110a in POMC neurons is required to maintain basal HGP
and insulin sensitivity.
DISCUSSION
The first major finding in this study is that CNSGLP-2R activation
suppresses HGP under both basal and hyperinsulinemic condi-
tions. It is unknown if central GLP-2 plays any roles in the regu-
lation of glucose homeostasis and insulin sensitivity. We show
that chronic i.c.v. infusion of GLP-2 in the WT mice improved
glucose tolerance, suppressed basal HGP, and increased ARC
PomcmRNA abundance, suggesting that CNS GLP-2 promotes
glucose homeostasis probably through the central melanocortin
system. Leptin direct action on POMC neurons lowers glucagon
levels and improves hepatic insulin sensitivity but does not influ-
ence insulin-stimulated glucose disposal. Analogously, POMC-
Glp2r KO mice display a reversed metabolic phenotype (i.e.,
increased glucose intolerance, displayed hepatic insulin resis-
tance, and impaired insulin-inhibited glucagon secretion, but un-
altered insulin-stimulated glucose disposal), suggesting that
GLP-2R in POMC neurons plays a physiological role in the con-
trol of glucose homeostasis. We speculate that GLP-2, secreted
from enteroendocrine L cells in response to food intake and
probably transported across the semipermeable blood-brain
barrier in the hypothalamus, activates GLP-2R in POMC neurons
to initiate a negative feedback control of HGP at the postprandial
condition. In addition, GLP-1/GLP-2 are released from PPG-
positive neurons in the brainstem NTS. PPG-GFP neurons proj-
ect widely to the mouse autonomic control areas (including the
hypothalamic ARC) (Llewellyn-Smith et al., 2011). PPG neurons
are directly excited by leptin and accounted in part for its anti-
obesity action, yet little is known about downstream neural
transmission. Thus, GLP-2 (released from PPG neurons in the
brainstem NTS) might function as a key neural transmitter in
the hypothalamic-brainstem neurocircuits to fine-tune glucose
homeostasis (including HGP) and energy balance. Regardless
of GLP-2 origin, our results indicate that GLP-2R activation in
POMC neurons is required for maintaining glucose homeostasis
and insulin sensitivity. This HGP-suppressing action is physio-
logically and pharmacologically important since excessive
HGP is a hallmark of T2DM patients. In future studies, it will be
important to determine if enhanced CNS GLP-2 signaling is a
key contributor to improving glucose homeostasis and insulin
sensitivity in diabetes after gastric bypass surgery.
The second major finding is that GLP-2 differentially modu-
lates membrane excitability of POMC neurons in GLP-2R- and
PI3K-dependent manners. GLP-2 directly depolarizes LepR-
positive POMC neurons or hyperpolarizes InsR-positive POMC
neurons. To sort out if GLP-2-mediated action on POMC neu-
rons is attributed to cell-autonomous and presynaptic effects,we found that under the presence of TTX, GLP-2 still has a direct
action on the membrane depolarization (or hyperpolarization).
Therefore, GLP-2 action on POMC neurons cannot be attributed
to action potential-dependent presynaptic transmission. In fact,
GLP-2-mediated effects are abolished in POMC neurons with
Glp2r deletion, pointing again to a direct action of GLP-2-
GLP-2R on membrane potential. Moreover, in the presence of
the PI3K inhibitor, GLP-2-induced depolarization and excitation
were blocked in POMC neurons, indicating a PI3K-dependent
action. Furthermore, activation of K+ATP channels was attributed
to GLP-2-induced inhibition of POMC neurons (Figure S3). In the
context of regulating Ca2+ influx, GLP-2R interacts in vitro with
calmodulin (Mahon and Shimada, 2005), a protein partner with
TRPC channels (Nilius et al., 2007).
Our finding that GLP-2 differentially affects membrane excit-
ability of POMC neurons in distinct subgroups is consistent
with the functional heterogeneity of hypothalamic POMC neu-
rons (Williams et al., 2010). For example, leptin-responsive
POMC neurons (i.e., acutely activated by leptin) are segregated
from insulin-responsive POMC neurons (i.e., acutely inhibited by
insulin). PI3K signaling is essential for leptin-induced activation
and insulin-induced inhibition of POMC neurons. Leptin
and serotonin depolarize POMC neurons via PI3K-dependent
PLCg-generated diacylglycerol activation of TRPC channels
(Sohn et al., 2011); in contrast, insulin hyperpolarizes POMCneu-
rons via PI3K-generated PIP3 activation of KATP channels (Plum
et al., 2006). Therefore, through activating the GLP-2R-PI3K
signaling pathway, GLP-2 depolarizes LepR-positive POMC
neurons while hyperpolarizing InsR-positive POMC neurons,
both resulting in decreases in HGP. However, distinct properties
and functions of these subgroups of POMC neurons are
currently unclear. Further studies are warranted to define
GLP-2R-mediated action on ion channel activities of POMC neu-
rons in segregated subgroups, which will ultimately determine
GLP-2-mediated modulation of glucose homeostasis.
The third major finding is that GLP-2 activates GLP-2R-PI3K
signaling in POMC neurons. As mentioned earlier, PI3K signaling
is essential for leptin-induced depolarization and insulin-induced
hyperpolarization of POMC neurons, resulting from enhanced
activities of TRPC channels and KATP channels, respectively
(Hill et al., 2008; Plum et al., 2006; Sohn et al., 2011). Through
inducing GLP-2R-p85a interaction, GLP-2 rapidly phosphory-
lates Akt in primary neurons in a PI3K-dependent manner (Shi
et al., 2011). Moreover, p85a binding motif on GLP-2R is
required for GLP-2 to induce Akt full activation in transfected
HEK cells (Figure S4). These data suggest that the PI3K-Akt
signaling pathway may underlie GLP-2-induced modulation of
POMC neurons. Basal PI3K signaling in POMC neurons is
severely compromised in POMC-Glp2r KO mice as indicated
by decreases in Akt phosphorylation and FoxO1 nuclear exclu-
sion. In contrast, GLP-2 activates PI3K-Akt-FoxO1 signaling in
POMC neurons (as indicated by increases in Akt phosphoryla-
tion and FoxO1 nuclear exclusion), and this effect is abolished
in the brain slices from mice with deletion of Glp2r or p110a in
POMC neurons. As reported, the basal PI3K activity in POMC
neurons is attenuated in POMC-p110a KO mice (Al-Qassab
et al., 2009). Moreover, PI3K activation also induces nuclear
exclusion of FoxO1, abrogating FoxO1’s inhibition of Pomc
and Cpe expression (Kim et al., 2006). Thus, p110a deletion inCell Metabolism 18, 86–98, July 2, 2013 ª2013 Elsevier Inc. 95
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the expression and release of a-MSH. Combined with our data
that GLP-2 enhances Akt phosphorylation via initiating GLP-
2R-p85a interaction and GLP-2 activates the PI3K-Akt-FoxO1
signaling in POMC neurons, we conclude that GLP-2 has a direct
action on membrane excitability of POMC neurons via activating
GLP-2R-PI3K signaling. Thus, we speculate that via the same
PI3K signaling cascade as leptin and insulin, GLP-2may activate
TRPC channels, exciting LepR-expressing POMC neurons, or
activate KATP channels, inhibiting InsR-expressing POMC neu-
rons as shown in our proposedmodel (Figure 6I). However, addi-
tional studies are warranted to test this speculation in the future.
The fourth major finding is that PI3K in POMC neurons is
required for CNS GLP-2-mediated suppression of HGP. The
PI3K signaling pathway in POMC neurons is involved not only
in energy balance but also glucose homeostasis (Morton et al.,
2005; Hill et al., 2009). Increased PI3K-Akt activity in POMC neu-
rons improves insulin sensitivity, whereas decreased PI3K-Akt
signaling impairs glucose homeostasis through a hypothala-
mus-vagal-liver neurocircuit (German et al., 2009). Direct action
of insulin and leptin on POMC neurons is required to maintain
glucose homeostasis (Hill et al., 2010; Obici et al., 2002). Local
infusion of GLP-1 into the ARC decreases HGP (Sandoval
et al., 2008). Mice with p85a (or p110a) deletion in POMC neu-
rons display improved (or impaired) insulin sensitivity (Hill et al.,
2009), while mice with PDK1 deletion in POMC neurons exhibit
hyperglycemia (Belgardt et al., 2008), which links to increased
FoxO1 nuclear localization (in POMC neuron) and decreased
Pomc gene expression. In this study, we found that p110a dele-
tion in POMC neurons lowers basal HGP, but reduces whole-
body insulin sensitivity, pointing out that PI3K signaling in
POMC neurons is required not only for basal glucose homeosta-
sis (basal HGP), but also for insulin sensitivity. Moreover, i.c.v.
infusion of GLP-2 suppresses HGP; however, this suppression
is abolished in POMC-p110a KO mice.
POMC neurons are not only localized in the hypothalamic
ARC, but also in the brainstem NTS. Theoretically, POMC-Cre-
mediated recombination might occur in POMC neurons within
these two nuclei. However, POMC-Cre is expressed mainly in
the ARC (Balthasar et al., 2004). In this study, we cannot defini-
tively define the physiological role of GLP-2R in POMC neurons
at the nuclei-specific or the subtype-specific manner. Of note,
POMC-Cre is transiently expressed in embryonic non-POMC
neurons in the brain (Padilla et al., 2012). Ultimately, the
POMC-Cre-mediated recombination of each floxed allele is
unique, depending upon endogenous recombination efficiency.
Except for the hypothalamus and hippocampus, Glp2r mRNA
andGLP-2R protein are not expressed in the brain regions where
POMC-Cre is highly transiently expressed (Padilla et al., 2012). It
is well documented that the hippocampus plays a major role in
memory and learning, but does not in metabolism. Moreover,
Glp2r mRNA expression in the hippocampus is not attenuated
in POMC-Glp2r KO. Thus, based on our in situ hybridization
and qRT-PCR data, we believe that the transient POMC-Cre
activity during development is not sufficient to induce GLP-2R
deletion in non-ARC regions (such as hippocampus).
In summary, we demonstrate the following. (1) Glp2r deletion
in POMC neurons impairs glucose tolerance and hepatic insulin
sensitivity. Glp2r activation in POMC neurons is required for96 Cell Metabolism 18, 86–98, July 2, 2013 ª2013 Elsevier Inc.GLP-2 to enhance insulin-mediated suppression of hepatic
HGP and gluconeogenesis. (2) GLP-2 directly modulates post-
synaptic membrane excitability of hypothalamic POMC neurons
in GLP-2R- and PI3K-dependent manners. (3) GLP-2 activates
the PI3K-Akt-FoxO1 signaling in POMC neurons by initiating
GLP-2R-p85a protein interaction, anchoring p-Akt membrane
localization, enhancing PI3K-dependent Akt phosphorylation,
and inducing PI3K-Akt-dependent nuclear exclusion of FoxO1-
GFP in POMC neurons. (4) i.c.v. GLP-2 augments glucose toler-
ance, suppresses basal HGP, and enhances insulin sensitivity,
which requires PI3K (p110a) activation in POMC neurons. We
conclude that CNS GLP-2 suppresses HGP at least in part
through directly modulating membrane excitability and nuclear
transcription of POMC neurons via activating the PI3K-Akt-
FoxO1 signaling pathway. Thus, GLP-2R activation in POMC
neurons is essential for the maintenance of energy balance
and glucose homeostasis.EXPERIMENTAL PROCEDURES
The protocols of this study were approved by the Animal Care and Use
Committee of Baylor College of Medicine. Transgenic mice were generated
using the Cre-LoxP system and provided ad libitum access to water and
food. Experimental Procedures in detail are provided in the Supplemental
Information.
Assessing Glucose Homeostasis and Insulin Sensitivity Using
Hyperinsulinemic Euglycemic Clamp
Glp2rflox/flox (or p110aflox/flox) mice were crossed with POMC-Cre+/0 to
generate POMC-specific Glp2r (or p110a) WT mice and KO mice. To validate
Glp2r deletion in POMC neurons, Glp2r protein expression was determined by
immunohistochemistry and theGlp2rmRNA expression by in situ hybridization
(Wang andGuan, 2010; Guan et al., 2012). POMC-Glp2r (or p110a) WT and KO
male mice were i.c.v. infused with vehicle or GLP-2 (250 mM at a rate of
0.5 ml/hr) for the insulin clamp (Figure S2). In addition, POMC-Glp2r WT and
KO male mice were i.v. infused with vehicle or GLP-2 (at 500 pmol/kg/hr).
During the insulin clamp, mice were primed-continuously infused with stable
isotopic tracers (2H2O and 6,6-
2H2-D-glucose). Glucose kinetics was quanti-
fied in conscious mice at steady state. Hypothalamus and liver samples
were harvested for qRT-PCR, and blood samples were collected for insulin,
GLP-1, and glucagon concentrations by ELISA.
Defining GLP-2R Signaling in Neurons
To examine if GLP-2R directly interacts with PI3K regulatory subunit (p85a),
primary neurons were dissociated from the hippocampus and cultured
(Wang and Guan, 2010). On DIV 7, neurons were treated with vehicle or
GLP-2 (at 20 nM for 30 min) and harvested for coIP and immunoblotting.
Neurons cultured on slides were used for immunohistochemistry. GLP-2R-
p85a interaction was confirmed in HEK293 cells transiently transfected with
cDNAs of p85a and GLP-2R (expressing the p85a binding motif or its mutant
sequence). To further monitor FoxO1-eGFP nuclear-cytoplasmic shuttling,
(Rosa26)FoxO1-eGFP reporter mice were crossed with POMC-Cre for WT
mice and then bred with Glp2rflox/flox (or p110aflox/flox) mice for KO mice. Brain
slices (250 mm) were treated with vehicle or GLP-2 (at 20 nM for 30 min) and
immunostained for GFP and p-Akt.
Electrophysiological Recordings
To determine if GLP-2 directly modulates excitability of POMC neurons,
membrane potential and firing rate were measured by the whole-cell current
clamp recordings (Sohn et al., 2011) from POMC neurons in brain slices. For
electrophysiological recordings, POMC-GFP+/0 mice were crossed with
Glp2rflox/flox mice to obtain the WT mice and then bred with POMC-Cre+/0
mice to generate POMC-specific Glp2r KO mice. GLP-2 or other reagents
were applied to bath solution. After the patch-clamp recording, the cytoplasm
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single-cell RT-PCR.
Statistical Analysis
Using the mixed procedure (SAS 9.2), we analyzed data with the fixed effects
(including genotype, treatment, and time), the random effect (including indi-
vidual mouse), and repeated measures (at different time points in the same
mouse). Thus, a full model for analysis of covariance (ANCOVA) includes BW
(and/or lean mass), genotype (WT versus KO), treatment (vehicle versus
GLP-2 or inhibitor), and their interactions. Least-squares mean of each
variable was reported and difference considered significant at p < 0.05. Error
bars were indicated by SEM.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, three tables, and Supplemental
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